ABL to Attend PEGS Boston
Boston, MA – May 4, 2015 – ABL staff will attend the 11th Annual PEGS Boston conference being held at the Seaport World Trade Center in Boston, MA on May 4-8. The PEGS conference focuses on antibody and protein science research and the biologics industry. The areas of focus for this conference include:
- Manufacturing: Engineering, Protein Expression, and Analytical
- Immunotherapies: Cancer, Bioconjugates, and other Biotherapeutics
- Immunogenicity and Bioassays
Visit with ABL staff at booth 341 or contact us to schedule an appointment during the meeting.
About ABL, Inc.
ABL, Inc. is a global biomedical contract research and manufacturing organization dedicated to advancing vaccines, therapeutics and other biologic products. ABL has extensive experience working with diverse organizations, including the U.S. Government, biopharmaceutical companies and academic entities. Notable contract manufacturing services include process and assay development, cGMP biologics manufacturing of bulk drug substance, cGMP aseptic fill and finish of drug product, and QC analytics in the U.S. and Europe. ABL also maintains U.S. and European immunological and molecular laboratories to support preclinical and GCLP clinical sample processing and testing. ABL is a part of the Institut Mérieux, a group of companies dedicated to developing translational science for better patient care globally.
For more information visit www.ablinc.com or email us.
